Adrian W Quartel
CIK 1910132 · Chief Medical Officer · last filed 2026-02-02
Adrian W Quartel is a Chief Medical Officer who has filed 4 SEC Form 4 insider transactions across 2 companies since 2022. The most recent filing, for ZVRA, was dated Feb 2, 2026. Across all open-market trades the lifetime net is −$40.0K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $180.3K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$180.3K
2
4
-$40.0K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ZVRA | Chief Medical Officer | 14,256 | $12.65 | $180.3K | -$40.0K | 2 | 2026-02-02 |
| Acer Therapeutics Inc. (ACER) Delisted | Chief Medical Officer | — | $0.66 | — | $0 | 2 | 2023-03-16 |
Recent Filings
4 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-02-02 | ZVRA | Mixed | +6,800 | -$40.0K | EDGAR |
| 2025-03-27 | ZVRA | Grant (A) | — | $0 | EDGAR |
| 2023-03-16 | Acer Therapeutics Inc. (ACER) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-02-23 | Acer Therapeutics Inc. (ACER) Delisted | Grant (A) | — | $0 | EDGAR |